Abstract
Magnesium sulfate is used as a tocolytic, but clinical efficacy has been seriously questioned. Our objective was to use controlled ex vivo conditions and known pregnancy stages, to investigate how 2 key factors, hormones and gestation, affect magnesium’s tocolytic ability. We hypothesized that these factors could underlie the varying clinical findings around magnesium’s efficacy. Myometrial strips were obtained from nonpregnant (n = 10), mid-pregnant (n = 12), and term-pregnant (n = 11) mouse uterus. The strips were mounted in organ baths superfused with oxygenated physiological saline at pH 7.4 and 37 °C. The effect of different concentrations of MgSO4 (2-20 mM) was examined on spontaneous and oxytocin-induced (0.5-1 nM) contractions. Contractile properties (amplitude, frequency, and area under the curve) were measured before and after application of magnesium. Magnesium sulfate had a dose-dependent inhibitory effect on both spontaneous and oxytocin-induced contractions but was less effective in the presence of oxytocin. In spontaneous contractions, magnesium was more potent as gestation progressed (P < .0001). In the presence of oxytocin, however, there were no significant gestational differences in its effects on contraction. The rapid onset and reversal of magnesium’s effects suggest an extracellular action on calcium entry. Taken together, we conclude that magnesium’s actions are influenced by both gestational state and hormones, such that, at least in mice, it is least effective in early gestation with oxytocin present and most effective at term in the absence of oxytocin. That magnesium is least effective preterm and oxytocin decreases its effectiveness throughout gestation, may explain its disappointing clinical effects as a tocolytic.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Cypher RL. Reducing recurrent preterm births: best evidence for transitioning to predictive and preventative strategies. J Perinat Neonatal Nurs. 2012;26(3):220–9.
Hall DG, McGaughey HS Jr, Corey EL, Thornton WN Jr. The effects of magnesium therapy on the duration of labour. Am J Obstet Gynecol. 1959;78(1):27–32.
Crowther CA, Brown J, McKinlay CJD, Middleton P. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev. 2014;(8
Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev. 2002;(4):CD001060
Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. New Engl J Med. 1995;333(4):201–5.
Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with preeclampsia. Cochrane Database Syst Rev. 2010;(11):CD000025.
Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009;(1): CD004661.
Gourgoulianis KI, Chatziparasidis G, Chatziefthimiou A, Molyvdas PA. Magnesium as a relaxing factor of airway smooth muscles. J Aerosol Med. 2001;14(3):301–7.
D’Angelo EK, Singer HA, Rembold CM. Magnesium relaxes arterial smooth muscle by decreasing intracellular Ca2+ without changing intracellular Mg2+. J Clin Invest. 1992;89(6):1988–94.
Kantas E, Cetin A, Kaya T, Cetin M. Effect of magnesium sulfate, isradipine, and ritodrine on contractions of myometrium: pregnant human and rat. Acta Obstet Gynecol Scand. 2002;81(9):825–30.
Kawarabayashi T, Kishikawa T, Sugimori H. Effects of external calcium, magnesium, and temperature on spontaneous contractions of pregnant human myometrium. Biol Reprod. 1989;40(5):942–8.
Tica VI, Tica AA, Carlig V, Banica OS. Magnesium ion inhibits spontaneous and induced contractions of isolated uterine muscle. Gynecol Endocrinol. 2007;23(7):368–72.
Popper LD, Batra SC. Å kerlund M. The effect of magnesium on calcium uptake and contractility in the human myometrium. Gynecol Obstet Invest. 1989;28(2):78–81.
Arrowsmith S, Neilson J, Wray S. The combination tocolytic effect of magnesium sulfate and an oxytocin receptor antagonist in myometrium from singleton and twin pregnancies. Am J Obstet Gynecol. 2016;215(6):789. e781-789. e789.
Phillippe M. Cellular mechanisms underlying magnesium sulfate inhibition of phasic myometrial contractions. Biochem Biophys Res Commun. 1998;252(2):502–7.
Tezuka N, Ali M, Chwalisz K, Garfield RE. Changes in transcripts encoding calcium channel subunits of rat myometrium during pregnancy. Am J Physiol. 1995;269(4 pt 1):C1008–17.
Mershon JL, Mikala G, Schwartz A. Changes in the expression of the L-type voltage-dependent calcium channel during pregnancy and parturition in the Rat1. Biol Reprod. 1994;51(5):993–9.
Collins PL, Moore JJ, Lundgren DW, Choobineh E, Chang SM, Chang AS. Gestational changes in uterine L-type calcium channel function and expression in guinea pig. Biol Reprod. 2000;63(5):1262–70.
Arrowsmith S, Wray S. Oxytocin: its mechanism of action and receptor signalling in the myometrium. J Neuroendocrinol. 2014;26(6):356–69.
Luckas MJ, Taggart MJ, Wray S. Intracellular calcium stores and agonist-induced contractions in isolated human myometrium. Am J Obstet Gynecol. 1999;181(2):468–76.
Matthew A, Kupittayanant S, Burdyga T, Wray S. Characterization of contractile activity and intracellular Ca2+ signalling in mouse myometrium. J Soc Gynecol Investig. 2004;11(4):207–12.
Blanks AM, Shmygol A, Thornton S. Regulation of oxytocin receptors and oxytocin receptor signaling. Semin Reprod Med. 2007;25(1):52–9.
Byrns MC. Regulation of progesterone signaling during pregnancy: implications for the use of progestins for the prevention of preterm birth. J Steroid Biochem Mol Biol. 2014;139:173–81.
Shynlova O, Tsui P, Jaffer S, Lye SJ. Integration of endocrine and mechanical signals in the regulation of myometrial functions during pregnancy and labour. Eur J Obstet Gynecol Reprod Biol. 2009;144(suppl 1):S2–S10.
Breuiller-Fouche M, Charpigny G, Germain G. Functional genomics of the pregnant uterus: from expectations to reality, a compilation of studies in the myometrium. BMC Pregnancy Childbirth. 2007;7(suppl 1):S4.
Garfield RE, Saade G, Buhimschi C, et al. Control and assessment of the uterus and cervix during pregnancy and labour. Hum Reprod Update. 1998;4(5):673–95.
Sugawara N, Okawa T, Takahashi H, et al. Influence of lipopolysaccharide on the uterine contraction inhibitory effects of tocolytic agents in pregnant mice. Am J Perinatol. 2007;24(9):557–62.
Jones K, Shmygol A, Kupittayanant S, Wray S. Electrophysiological characterization and functional importance of calciumactivated chloride channel in rat uterine myocytes. Pflugers Arch. 2004;448(1):36–43.
Babiychuk EB, Smith RD, Burdyga T, Babiychuk VS, Wray S, Draeger A. Membrane cholesterol regulates smooth muscle phasic contraction. J Membr Biol. 2004;198(2):95–101.
Grimes DA, Nanda K. Magnesium sulfate tocolysis: time to quit. Obstet Gynecol. 2006;108(4):986–9.
Hacivelioglu S, Cirpan T, Cosan Terek M, Kanit L, Kazandi M, Oztekin K. In vitro effects of ritodrine, magnesium sulfate and their combination on spontaneous contractions of myometrial strips of pregnant rat uteri. Clin Exp Obstet Gynecol. 2007;34(4):223–7.
Keirse MJ. The history of tocolysis. BJOG. 2003;110(suppl 20):94–7.
Onwochei DN, Carvalho JCA, Luca A, Balki M, Kingdom J. Effect of magnesium sulfate on oxytocin-induced contractility in human myometrium: an in vitro study. Can J Anesth. 2017;64(7):744–53.
Fomin VP, Gibbs SG, Vanam R, Morimiya A, Hurd WW. Effect of magnesium sulfate on contractile force and intracellular calcium concentration in pregnant human myometrium. Am J Obstet Gynecol. 2006;194(5):1384–90.
Martin RW, Gaddy DK, Martin JN Jr, Lucas JA, Wiser WL, Morrison JC. Tocolysis with oral magnesium. Am J Obstet Gynecol. 1987;156(2):433–4.
Lau LC, Adaikan PG, Arulkumaran S, Ng SC. Oxytocics reverse the tocolytic effect of glyceryl trinitrate on the human uterus. BJOG. 2001;108(2):164–8.
Szal SE, Croughan-Minihane MS, Kilpatrick SJ. Effect of magnesium prophylaxis and preeclampsia on the duration of labor. Am J Obstet Gynecol. 1999;180(6 Pt 1):1475–9.
Graham NM, Gimovsky AC, Roman A, Berghella V. Blood loss at cesarean delivery in women on magnesium sulfate for preeclampsia. J Matern Fetal Neonatal Med. 2016;29(11):1817–21.
Wray S, Kupittayanant S, Shmygol A, Smith RD, Burdyga T. The physiological basis of uterine contractility: a short review. Exp Physiol. 2001;86(2):239–46.
Wray S, Jones K, Kupittayanant S, et al. Calcium signaling and uterine contractility. J Soc Gynecol Investig. 2003;10(5):252–64.
Shmigol AV, Eisner DA, Wray S. Simultaneous measurements of changes in sarcoplasmic reticulum and cytosolic [Ca(2+)] in rat uterine smooth muscle cells. J Physiol. 2001;531(Pt 3):707–13.
Wray S, Burdyga T, Noble D, Noble K, Borysova L, Arrowsmith S. Progress in understanding electro-mechanical signalling in the myometrium. Acta Physiol (Oxf). 2015;213(2):417–31.
Tang YY, Du Y, Ni J, Ma YS, Lin XM, Zhou J. Relaxant effects of metoclopramide and magnesium sulfate on isolated pregnant myometrium: an in vitro study. Int J Obstet Anesth. 2014;23(2):131–7.
Matsuda H, Kurata Y, Oka C, Matsuoka S, Noma A. Magnesium gating of cardiac gap junction channels. Prog Biophys Mol Biol. 2010;103(1):102–10.
Rimkute L, Kraujalis T, Snipas M, et al. Modulation of connexin- 36 gap junction channels by intracellular pH and magnesium ions. Front Physiol. 2018;9:362.
Dodds KN, Staikopoulos V, Beckett EA. Uterine contractility in the nonpregnant mouse: changes during the estrous cycle and effects of chloride channel blockade. Biol Reprod. 2015;92(6):141.
Wray S, Noble K. Sex hormones and excitation–contraction coupling in the uterus: the effects of oestrous and hormones. J Neuroendocrinol. 2008;20(4):451–61.
Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001;81(2):629–83.
Noble K, Zhang J, Wray S. Lipid rafts, the sarcoplasmic reticulum and uterine calcium signalling: an integrated approach. J Physiol. 2006;570(Pt 1):29–35.
Smith RD, Babiychuk EB, Noble K, Draeger A, Wray S. Increased cholesterol decreases uterine activity: functional effects of cholesterol alteration in pregnant rat myometrium. Am J Physiol Cell Physiol. 2005;288(5):C982–8.
Draeger A, Wray S, Babiychuk EB. Domain architecture of the smooth-muscle plasma membrane: regulation by annexins. Biochem J. 2005;387(Pt 2):309–14.
Kimura T, Tanizawa O, Mori K, Brownstein MJ, Okayama H. Structure and expression of a human oxytocin receptor. Nature. 1992;356(6369):526–9.
Kubota Y, Kimura T, Hashimoto K, et al. Structure and expression of the mouse oxytocin receptor gene. Mol Cell Endocrinol. 1996;124(1):25–32.
Wray S. Insights into the uterus. Exp Physiol. 2007;92(4):621–31.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Osaghae, B.E., Arrowsmith, S. & Wray, S. Gestational and Hormonal Effects on Magnesium Sulfate’s Ability to Inhibit Mouse Uterine Contractility. Reprod. Sci. 27, 1570–1579 (2020). https://doi.org/10.1007/s43032-020-00185-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43032-020-00185-8